Magnetic guidance could make liver tumor radiation safer and more effective
NCT ID NCT05027711
First seen Mar 11, 2026 · Last updated Jun 17, 2026 · Updated 10 times
Summary
This study compares a new type of radiation therapy (MR-guided adaptive SBRT) to standard radiation for people with up to 3 liver tumors that started in another organ. The new method uses real-time MRI to better target the tumors and avoid harming nearby organs. About 90 adults will take part to see if the new approach causes fewer serious side effects while still controlling the tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC METASTASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital of Heidelberg, Radiation Oncology
RECRUITINGHeidelberg, 69120, Germany
Contact
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.